NCT03931876View on ClinicalTrials.gov

A Single Ascending Dose Study of AV-006 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

November 1, 2019

Conditions
Bacterial Infections
Interventions
DRUG

Placebos

Single ascending dose administration

DRUG

AV-006

Single ascending dose administration

Trial Locations (1)

3004

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Arixa Pharmaceuticals

INDUSTRY

NCT03931876 - A Single Ascending Dose Study of AV-006 in Healthy Subjects | Biotech Hunter | Biotech Hunter